Boone Hospital Home Care & Hospice 1605 E Broadway, Ste 250, Columbia, MO, 65201 | |
(573) 875-0555 |
News Archive
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
A study published today in Neuron offers the first evidence that lack of this protein - known as RIM1 alpha - causes profound deficits in the learning process. The discovery is a major step in understanding the molecular events that underlie learning and memory - complex processes that can be impaired in human neuropsychiatric disorders such as Alzheimer's disease, mental retardation and schizophrenia.
› Verified 2 days ago
Name | Boone Hospital Home Care & Hospice |
---|---|
Location | 1605 E Broadway, Ste 250, Columbia, Missouri |
Hospice ID | 261565 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
SSA county code | 090 |
News Archive
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
A study published today in Neuron offers the first evidence that lack of this protein - known as RIM1 alpha - causes profound deficits in the learning process. The discovery is a major step in understanding the molecular events that underlie learning and memory - complex processes that can be impaired in human neuropsychiatric disorders such as Alzheimer's disease, mental retardation and schizophrenia.
› Verified 2 days ago
NPI Number | 1417971953 |
Organization Name | Boone Hospital Center's Visiting Nurses, Inc. |
Address | 1605 E. Broadway Columbia, Missouri, 65201 |
Phone Number | (573)875-0555 |
News Archive
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
A study published today in Neuron offers the first evidence that lack of this protein - known as RIM1 alpha - causes profound deficits in the learning process. The discovery is a major step in understanding the molecular events that underlie learning and memory - complex processes that can be impaired in human neuropsychiatric disorders such as Alzheimer's disease, mental retardation and schizophrenia.
› Verified 2 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.4 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.5 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 83.9 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.1 | 97.3 |
Patients who got timely treatment for shortness of breath | 96.5 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 93.1 | 93.3 |
News Archive
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
A study published today in Neuron offers the first evidence that lack of this protein - known as RIM1 alpha - causes profound deficits in the learning process. The discovery is a major step in understanding the molecular events that underlie learning and memory - complex processes that can be impaired in human neuropsychiatric disorders such as Alzheimer's disease, mental retardation and schizophrenia.
› Verified 2 days ago
Home Health Aides | 1.5 |
Counselors | 0.7 |
Homemakers | 0.5 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 0.9 |
Physicians | 0.1 |
Registered Nurses | 2 |
Total Employees | 6.7 |
---|
News Archive
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
A study published today in Neuron offers the first evidence that lack of this protein - known as RIM1 alpha - causes profound deficits in the learning process. The discovery is a major step in understanding the molecular events that underlie learning and memory - complex processes that can be impaired in human neuropsychiatric disorders such as Alzheimer's disease, mental retardation and schizophrenia.
› Verified 2 days ago
Others | 6 |
Total Volunteers | 6 |
---|
News Archive
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
Primary Ciliary Dyskinesia is mainly a lung disease: a rare, genetically heterogeneous disorder resulting from dysfunction of small hair-like organelles (cilia) that clean the upper and lower airways. It can also affect multiple organs beside the respiratory system, and may cause serious impairment and lower quality of life. Its prevalence is estimated to be about 1 in 16,000.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
A study published today in Neuron offers the first evidence that lack of this protein - known as RIM1 alpha - causes profound deficits in the learning process. The discovery is a major step in understanding the molecular events that underlie learning and memory - complex processes that can be impaired in human neuropsychiatric disorders such as Alzheimer's disease, mental retardation and schizophrenia.
› Verified 2 days ago
Boone Hospital Home Care & Hospice Location: 1605 E Broadway, Ste 250, Columbia, Missouri, 65201 Phone: (573) 875-0555 |
Preferred Hospice Of Missouri (central) Location: 1900 North Providence Road Suite 311, Columbia, Missouri, 65202 Phone: (573) 875-0555 |
Hospice Compassus-north Central Missouri Location: 3050 I-70 Drive Se - Suite 100, Columbia, Missouri, 65201 Phone: (573) 875-0555 |